Cargando…
No increased risk of dementia in patients receiving androgen deprivation therapy for prostate cancer: a 5-year follow-up study
Prior studies suggested that the use of androgen deprivation therapy (ADT) in patients with prostate cancer (PC) might cause the impairment of cognitive function which is one of the common symptoms of dementia; however, the association between ADT and cognitive impairment still remains controversial...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507085/ https://www.ncbi.nlm.nih.gov/pubmed/27232853 http://dx.doi.org/10.4103/1008-682X.179528 |